台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    67.3
  • 漲跌
    ▲1.4
  • 漲幅
    +2.12%
  • 成交量
    745
  • 產業
    上櫃 生技醫療類股▲1.26%
  • 73人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
易威 (1799)籌碼相關-元大-東港 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw06/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1001/2202/1402/2803/1203/2404/0604/1604/2805/08405060708090Jul '24Sep '24Nov '24Mar '25May '2560d90dAll

元大-東港 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/05/070.363.8300.0065.900.34810.06%
2025/04/3000.00260.2059.60-2470-0.42%
2025/04/29157.5000.0062.5014640.22%
2025/04/25157.0000.0056.7014630.22%
2025/04/21559.5000.0058.0054751.05%
2025/03/2500.001974.7976.00-19594-3.20%
2025/03/1900.00273.0072.60-2598-0.33%
2025/03/1800.00275.6075.50-2602-0.33%
2025/03/1400.001678.2677.70-16617-2.59%
2025/03/13480.0800.0081.0046030.66%
2025/03/121277.8200.0077.50125852.05%
2025/03/11678.08678.6381.5005570.00%
2025/03/102874.09176.8076.80275185.21%
2025/03/07471.38172.2069.9034960.60%
2025/03/0600.00469.3067.60-4483-0.83%
2025/03/03469.9000.0069.6044830.83%
2025/02/25169.2000.0067.7015030.20%
2025/02/20171.0000.0071.0014970.20%
2025/01/2000.00358.6061.00-3616-0.49%
2025/01/1700.001960.2158.60-19616-3.08%
2025/01/1600.00161.5061.40-1613-0.16%
2025/01/1400.001062.2062.90-10621-1.61%
2025/01/1300.002566.0662.80-25627-3.98%
2024/12/26168.0000.0066.6016920.14%
2024/12/251473.56475.4074.00106831.46%
2024/12/241069.6000.0073.00106771.48%
2024/12/20160.4000.0060.4016840.15%
2024/12/05167.0000.0065.5016550.15%
2024/12/0300.00167.0067.80-1662-0.15%
2024/12/0200.00267.1066.60-2663-0.30%
2024/11/28165.00164.2064.8006720.00%
2024/11/27268.5000.0066.5026770.30%
2024/11/26369.6000.0068.6036810.44%
2024/11/252972.3200.0071.90296814.26%
2024/11/221172.2900.0073.00116721.63%
2024/11/19267.4000.0067.4026670.30%
2024/11/13264.9000.0064.0026520.31%
2024/11/08180.0000.0077.8016030.17%
2024/11/07186.5000.0086.1016200.16%
2024/10/251101.0000.00100.0016870.15%
2024/10/0800.002123.75126.00-2839-0.24%
2024/10/0400.00392.63106.50-3813-0.37%
2024/09/301108.0000.00108.0017770.13%
2024/09/272120.0000.00120.0027960.25%
2024/09/261133.5000.00133.0017850.13%
2024/09/251146.5000.00147.5017840.13%
2024/09/0900.004194.50195.00-4808-0.49%
2024/08/1900.000.1200.50201.50-0.1820-0.01%
2024/08/121198.0000.00198.0018350.12%
2024/08/0800.001185.00187.00-1794-0.13%
2024/08/061172.0000.00171.0017770.13%
2024/07/220.1164.0000.00164.000.16670.01%
2024/07/1800.0012195.00196.50-12611-1.96%
2024/07/1700.005179.50191.00-5589-0.85%
2024/07/111149.5000.00149.0015310.19%
2024/07/0900.002140.00139.00-2499-0.40%
2024/07/0400.003126.50126.00-3477-0.63%
2024/07/039127.2212.5129.68124.50-3.5474-0.74%
2024/07/028138.1300.00138.0084461.79%
2024/07/019129.7800.00137.5094352.07%
2024/06/287121.1415122.90130.00-8413-1.93%
2024/06/272.5116.1000.00118.502.53930.63%
2024/06/2400.001106.00103.00-1368-0.27%
2024/06/1700.000.4108.00108.00-0.4353-0.11%
2024/06/1300.00295.2096.00-2329-0.61%
2024/06/122100.5000.0097.4023270.61%
2024/06/1116100.0900.00101.50163244.93%
2024/05/29195.0000.0094.5013190.31%
2024/05/27298.3000.00100.0023070.65%
2024/05/24399.0000.00105.0032981.00%
2024/05/21290.4000.0093.0022500.80%
2024/05/1700.00580.0078.50-5229-2.18%
2024/05/1400.00475.0074.30-4249-1.61%
2024/05/1000.00479.3076.50-4258-1.55%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音